News from MAX IV

Cubosomes web

Essential closer look at nanosized drug carriers 

Researchers have developed a protocol for studying how drug carrying nanoparticles called cubosomes behave in the body. The results show nanoparticle stability and confirm localisation in the cell. The study represents a significant step forward in the development of novel pharmaceuticals.

Guided by the light?

Come work with us!

The opportunity to a be part of building MAX IV is for many enough reason to join our team. But aside from tinkering with all our stunning technology, we also offer a wide array of benefits to everyone of our employees.

Vacancies at MAX IV chevron_right